The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.

Glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) agonists — originally developed to treat people with ...

The Atlanta-based medical weight loss company has big plans for Tampa Bay, including a large new facility and substantial ...

Shane Harding says she used to drink up to two bottles of wine a night before starting medication, which has helped her lose ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...